Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

131.87 -4.09 (-3.01%)
Official Closing Price Updated: 8:00 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Leading And Lagging Sectors For March 24, 2025
Via Benzinga
Surveying The Week Ahead In The Financial Markets
This week we get a lot of important economic data. 
Via Talk Markets
Topics Stocks / Equities
Leading And Lagging Sectors For March 21, 2025
Via Benzinga
Two Sectors Just Tried And Failed - And That’s Great For Us
Technology and healthcare have both tried for a breakout and failed, courtesy of massive economic forces rocking the boat. 
Via Talk Markets
Topics Stocks / Equities
US Sector Leadership Shifts, Favoring Healthcare Stocks
Via Talk Markets
Topics ETFs
Leading And Lagging Sectors For March 20, 2025
Via Benzinga
Leading And Lagging Sectors For March 19, 2025
Via Benzinga
Here Are The Winners And Losers At This Turning Point
After a torrid two-day short-covering rally which saw stocks gain as much as 3.7%, we're seeing a fresh round of selling in the U.S. market. 
Via Talk Markets
Topics ETFs Stocks / Equities
Leading And Lagging Sectors For March 18, 2025
Via Benzinga
Get Ready For The “Great Reflation” This Week
It’s important to realize that some of the biggest rallies in stocks often occur during bear trends. These come from short squeezes. 
Via Talk Markets
Topics Stocks / Equities
Leading And Lagging Sectors For March 17, 2025
Via Benzinga
Leading And Lagging Sectors For March 14, 2025
Via Benzinga
Inflation Isn’t Going Away, But These Sectors Don’t Care
The CPI and PPI releases this week came in more or less at estimates - nothing to alarm the talking heads, anyway. They show inflation slowing down but not receding. 
Via Talk Markets
Topics ETFs Economy Stocks / Equities
Exposures Interest Rates
Leading And Lagging Sectors For March 13, 2025
Via Benzinga
Leading And Lagging Sectors For March 12, 2025
Via Benzinga
Leading And Lagging Sectors For March 11, 2025
Via Benzinga
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled
Small caps took another step down this past week as geopolitical events dampened sentiment. 
Via Talk Markets
Topics ETFs Stocks / Equities
The Market Is Trying To Heal
The selling has been pretty orderly thus far. The meaning behind this runs deep. 
Via Talk Markets
Topics Stocks / Equities
Leading And Lagging Sectors For March 10, 2025
Via Benzinga
Healthcare Sector Trying To Bounce Back
I often discuss highly rated stocks that are part of highly rated sectors. Thus, this time is a departure from the norm. Let's dive into the data for the healthcare sector. 
Via Talk Markets
Topics ETFs Stocks / Equities
Leading And Lagging Sectors For March 7, 2025
Via Benzinga
Leading And Lagging Sectors For March 6, 2025
Via Benzinga
Leading And Lagging Sectors For March 5, 2025
Via Benzinga
Is It Time To Shift Focus To Beaten-Down Healthcare Stocks As Volatility Soars?
Healthcare performed terribly in 2023 and 2024, falling while the market was soaring. Year-to-date, the sector has outperformed. Is it time to focus on the stocks and ETFs of this low-Beta sector as... 
Via Talk Markets
Topics ETFs Stocks / Equities
Biotech Rally Coming In Weeks Ahead?
Large cap biopharma and MedTech stocks are leading the healthcare sector higher. 
Via Talk Markets
Topics ETFs Stocks / Equities
Leading And Lagging Sectors For March 4, 2025
Via Benzinga
Making Bets On The Money
The top-performing sector last week was financials, they closed up over 2.8% on the week at their highest weekly and monthly level in history. 
Via Talk Markets
Topics Stocks / Equities
Leading And Lagging Sectors For March 3, 2025
Via Benzinga
Leading And Lagging Sectors For February 28, 2025
Via Benzinga
Moderna Stock Heads For Weekly Loss As Retail Caution Prevails: Wealth Advisor Tells Why She's Staying On The Sidelines
The stock fell over 7% on Thursday after reports that federal health officials under the Trump administration are re-evaluating Moderna's $590 million contract for bird flu vaccine development. 
Via Stocktwits
Topics Government
Exposures Political
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.